Trending...
- C-Data Unveils Next-Gen Distributed PON Solution, Redefining PON Architecture
- BSTR Miner Introduces Hassle-Free Cloud Mining Solution for Crypto Enthusiasts
- Criptlán Partners with Top Capital and Technology Teams to Drive the Future of the Digital Economy
BOSTON, May 20, 2024 ~ Journalist: HotSpot Therapeutics, Inc. has announced that they will be presenting additional preclinical data from their MALT1 program at the 4th American Association for Cancer Research (AACR) International Meeting. The meeting, titled "Advances in Malignant Lymphoma," will take place from June 19-22, 2024 in Philadelphia, PA.
The company, known for pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as "natural hotspots," will be sharing their findings on the highly differentiated mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) program.
More on The PennZone
The presentation, titled "Targeting the CBM Signalosome with a MALT1 Scaffolding Inhibitor for Treatment of Non-Hodgkin Lymphomas," will take place on Thursday, June 20, 2024 from 5:30-7:30 PM ET at the Sheraton Philadelphia Downtown. The publication number for this presentation is PO-036.
HotSpot Therapeutics' innovative approach to targeting regulatory sites on proteins has shown promising results in their MALT1 program and could potentially lead to new treatments for non-Hodgkin lymphomas. The company's participation in the AACR International Meeting highlights their commitment to advancing cancer research and finding new ways to treat this disease.
The company, known for pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as "natural hotspots," will be sharing their findings on the highly differentiated mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) program.
More on The PennZone
- Announcing The Must-Read Crypto Playbook Of 2025!
- eLynxx Solutions Celebrates 50 Years of Innovation in Print Procurement
- Etan Polinger Officially Recognized As New Mexico's First Certified Ai Consultant
- Expert Law Attorneys Nominates 2025 Personal Injury Firms
- The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magic Magnesium Spray, Driving 200% Audience Growth
The presentation, titled "Targeting the CBM Signalosome with a MALT1 Scaffolding Inhibitor for Treatment of Non-Hodgkin Lymphomas," will take place on Thursday, June 20, 2024 from 5:30-7:30 PM ET at the Sheraton Philadelphia Downtown. The publication number for this presentation is PO-036.
HotSpot Therapeutics' innovative approach to targeting regulatory sites on proteins has shown promising results in their MALT1 program and could potentially lead to new treatments for non-Hodgkin lymphomas. The company's participation in the AACR International Meeting highlights their commitment to advancing cancer research and finding new ways to treat this disease.
Filed Under: Business
0 Comments
Latest on The PennZone
- Pan-Armenian Digital Trade Center Launched on Fastexverse
- Express Wash Concepts Announces Pittsburgh Expansion with Grand Opening of 11th Clean Express Auto Wash
- U.S. Army Selects Nokomis to Develop Passive Drone Detection, Tracking, and Identification System
- Stern Recruiting Launches with a Mission to Revolutionize Talent Acquisition
- Bonita Mitchell Releases Inspiring Single "Let This Mind Be In Me" From Book Soundtrack 'The First Lady'
- Webinar Announcement: Collaborating for Digital Transformation: Innovation, Governance, and the Future of Financial Operations
- ASI Holds Annual Executive Business Summit Showcasing Suite of Solutions & Celebrates 2024 Partner Award Winners
- Veterans for America First condemns a faith-based smear campaign against Muslim Candidate Sophia Farooq in Cobb County Georgia as Integrity Matters
- Nigeria is next biggest crypto-mining country - Oneminers is investing millions
- Maxfli Announces Golf Ball Partnership with Renowned Instructor Sean Foley
- Corcoran DeRonja Real Estate Welcomes Mechelle Fuquay as Its Newest Broker
- Matt Stuckert Joins Lineus Medical Board of Directors
- Fray Fitness Launches Redesigned Website to Enhance Customer Experience
- Rampage Jackson and Rashad Evans Face Off At Press Conference At The Palms Casino Resort in Las Vegas on March 20, 2025
- Pain Relief Specialist in Coopersburg Offers Comprehensive Care for Chronic Pain Sufferers
- Exeter Smiles Brings Braces to Allentown Area Residents
- DICE Dental Preventing Tooth Decay in Bethlehem
- Drone Light Shows Become the Must-Have Entertainment Trend for Events and Venues
- InventHelp Inventor Develops Modified Beach Wagon (PLB-419)
- Allentown-Based Grace Montessori School to Host its Legacy of Learning Annual Benefit on May 15